The claim came from a post on November 20 about 'The View' discussing the nomination of Dr Mehmet Oz to run the Centers for ...
The Biden administration is attempting to push through a slew of reforms to the controversial MA program in its final months ...
The Centers for Medicare and Medicaid Services draft regulation also would introduce Medicare and Medicaid coverage of ...
The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.
The nomination of Dr. Mehmet Oz to head the Centers for Medicare and Medicaid Services (CMS) has stirred debates about the future of federal health programs under the incoming Trump administration.
Washington — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden ...
Maximus announces CMS has canceled the early re-procurement of its Medicare contract, allowing the company to continue its current work until 2031.
The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic and Wegovy for people with Medicare and Medicaid through a new proposal from the Department of Health and Human ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration. By Margot Sanger-Katz Margot Sanger-Katz has been ...
The Centers for Medicare and Medicaid Services (CMS) announced that 2025 monthly Part B premiums will climb to $185, an increase of $10.30 from $174.70 in 2024. And the annual Part B deductible ...
Some 3.4 million Medicare beneficiaries and about 4 million Medicaid recipients would gain access to these medications, which can cost as much as $1,000 a month for the uninsured, the White House ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback